Stanford accelerated intelligent neuromodulation therapy for treatment-resistant depression EJ Cole, KH Stimpson, BS Bentzley, M Gulser, K Cherian, C Tischler, ... American Journal of Psychiatry 177 (8), 716-726, 2020 | 565 | 2020 |
Stanford neuromodulation therapy (SNT): a double-blind randomized controlled trial EJ Cole, AL Phillips, BS Bentzley, KH Stimpson, R Nejad, F Barmak, ... American Journal of Psychiatry 179 (2), 132-141, 2022 | 475 | 2022 |
High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression NR Williams, KD Sudheimer, BS Bentzley, J Pannu, KH Stimpson, ... Brain 141 (3), e18-e18, 2018 | 182 | 2018 |
HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition K Cherian, AF Schatzberg, J Keller Schizophrenia research 213, 72-79, 2019 | 95 | 2019 |
Magnesium–ibogaine therapy in veterans with traumatic brain injuries KN Cherian, JN Keynan, L Anker, A Faerman, RE Brown, A Shamma, ... Nature Medicine 30 (2), 373-381, 2024 | 20 | 2024 |
Multiculturalism: A challenge for cognitive screeners in Parkinson's disease M Statucka, K Cherian, A Fasano, RP Munhoz, M Cohn Movement Disorders Clinical Practice 8 (5), 733-742, 2021 | 10 | 2021 |
& Williams, NR (2020) EJ Cole, KH Stimpson, BS Bentzley, M Gulser, K Cherian, C Tischler Stanford accelerated intelligent neuromodulation therapy for treatment …, 0 | 8 | |
Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin BJ Tabaac, K Shinozuka, A Arenas, BD Beutler, K Cherian, VD Evans, ... American Journal of Therapeutics 31 (2), e121-e132, 2024 | 7 | 2024 |
Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview BJ Tabaac, K Shinozuka, A Arenas, BD Beutler, K Cherian, VD Evans, ... American Journal of Therapeutics 31 (2), e97-e103, 2024 | 6 | 2024 |
Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD) BD Beutler, K Shinozuka, BJ Tabaac, A Arenas, K Cherian, VD Evans, ... American Journal of Therapeutics 31 (2), e104-e111, 2024 | 5 | 2024 |
Psychedelic Therapy: A Primer for Primary Care Clinicians—N, N-Dimethyltryptamine and Ayahuasca K Shinozuka, BJ Tabaac, A Arenas, BD Beutler, K Cherian, VD Evans, ... American Journal of Therapeutics 31 (2), e112-e120, 2024 | 4 | 2024 |
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT-TRD) induces rapid remission from treatment-resistant depression in a double-blinded, randomized, and controlled … AL Phillips, EJ Cole, BS Bentzley, KH Stimpson, R Nejad, C Tischler, ... Brain Stimulation: Basic, Translational, and Clinical Research in …, 2020 | 4 | 2020 |
Psychedelic Therapy: A Primer for Primary Care Clinicians—3, 4-Methylenedioxy-methamphetamine (MDMA) K Shinozuka, BJ Tabaac, A Arenas, BD Beutler, K Cherian, VD Evans, ... American Journal of Therapeutics 31 (2), e141-e154, 2024 | 3 | 2024 |
Psychedelic Therapy: A Primer for Primary Care Clinicians—The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics OS Muir, K Shinozuka, BD Beutler, A Arenas, K Cherian, VD Evans, ... American Journal of Therapeutics 31 (2), e178-e182, 2024 | 2 | 2024 |
Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine K Cherian, K Shinozuka, BJ Tabaac, A Arenas, BD Beutler, VD Evans, ... American Journal of Therapeutics 31 (2), e133-e140, 2024 | 2 | 2024 |
Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine VD Evans, A Arenas, K Shinozuka, BJ Tabaac, BD Beutler, K Cherian, ... American Journal of Therapeutics 31 (2), e155-e177, 2024 | 2 | 2024 |
Repetitive transcranial magnetic stimulation for post‐traumatic stress disorder in adults R Brown, K Cherian, K Jones, R Wickham, R Gomez, G Sahlem Cochrane Database of Systematic Reviews, 2024 | 2 | 2024 |
T162. High-Dose Spaced Theta-Burst Transcranial Magnetic Stimulation as a Rapid-Acting Anti-Depressant in Highly Refractory Depression N Williams, K Sudheimer, B Bentzley, J Pannu, K Stimpson, D Duvio, ... Biological Psychiatry 83 (9), S191, 2018 | 1 | 2018 |
Psychedelic Therapy: A Primer for Primary Care Clinicians–Part IV. Psilocybin BJ Tabaac, K Shinozuka, A Arenas, BD Beutler, K Cherian, VD Evans, ... | | 2023 |
22 The Effect of Ibogaine on Cognitive Functioning KN Cherian, A Faerman, LA Anker, RE Brown, O Keynan, J Keller, ... Journal of the International Neuropsychological Society 29 (s1), 898-899, 2023 | | 2023 |